Загрузка...

Recombinant human erythropoietin versus placebo or no treatment for the anaemia of chronic kidney disease in people not requiring dialysis

BACKGROUND: Treatment with recombinant human erythropoietin (rHuEPO) in dialysis patients has been shown to be highly effective in terms of correcting anaemia and improving quality of life. There is debate concerning the benefits of rHuEPO use in predialysis patients which may accelerate the deterio...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Cochrane Database Syst Rev
Главные авторы: Cody, June D, Hodson, Elisabeth M
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley & Sons, Ltd 2016
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7144724/
https://ncbi.nlm.nih.gov/pubmed/26790135
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD003266.pub3
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!